Aidspan publishes new issue of 'Global Fund Observer'

NewsGuard 100/100 Score
Dec 1 2012

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Friday published Issue 204 of its "Global Fund Observer." Among other articles, the issue features an article on the resolution of a stalemate over a grant to Zambia; an article summarizing the latest report from the Global Fund's Office of the Inspector General; and an article on a proposed new AIDS funding rule in Brazil (11/30).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Posted in: Disease/Infection News | Healthcare News

Tags: , , , , , , ,

Comments (0)

Suggested Reading

Study reveals lasting lung damage in tuberculosis survivors
Enzymatic cocktail emerges as new hope against mycobacterial infections
New malaria vaccine strain shows promise in preclinical trials
Pioneering study launched to examine how the immune system responds to repeated malaria infections
Redefining tuberculosis classification to enhance early detection and treatment
Ministers of Health commit to accelerated action against malaria in Africa
Leveraging cancer therapies to combat tuberculosis
Oxford University and Brazil partner to advance malaria vaccine development

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
The path to a better tuberculosis vaccine runs through Montana